Hafeez Rajwani MSc

Hafeez Rajwani is a physician–scientist with a strong background in global health, academic medicine, and critical care. Prior to entering medical school, he worked with the United Nations, an experience that shaped his interest in health systems, international collaboration, and evidence-based policy. He graduated with distinction from St George’s, University of London, earning his MBBS and establishing a foundation in both clinical excellence and academic inquiry.

Following medical school, Dr. Rajwani pursued advanced postgraduate training at the University of Oxford, where he completed a Master of Science in Experimental and Translational Therapeutics with first-class honors. His graduate training focused on bridging laboratory science with clinical application, equipping him with expertise in drug development, translational research, and early-phase clinical trials. This academic training laid the groundwork for his later work in clinical trial design and investigational therapeutics.

Dr. Rajwani completed his anesthesia residency at the University of Iowa, where he gained comprehensive training in perioperative medicine, critical physiology, and patient safety. He subsequently undertook a fellowship in Critical Care Medicine within the Mass General Brigham system at Harvard Medical School, one of the world’s leading academic medical centers. During this period, he refined his expertise in managing complex critical illness, including septic shock, post–cardiac arrest care, and neurocritical conditions.

A published and award-recognized academic, Dr. Rajwani has contributed to the medical literature across anesthesia, critical care, and neurocritical care. His research interests include septic shock, extracorporeal membrane oxygenation, postoperative airway management, and disorders of consciousness. He has been particularly involved in clinical trial design, applying rigorous methodological approaches to both observational and interventional studies. Ongoing and preparatory projects include investigations into hyperbaric oxygen therapy for septic shock and electroencephalographic algorithms to predict neurological recovery following cardiac arrest.

In addition to his clinical and academic work, Dr. Rajwani has contributed to research and development initiatives at leading institutions, including the University of Oxford, the University of Cambridge, and the University of Iowa. His work has spanned neuroimaging validation, multicenter randomized controlled trial planning, medical textbook authorship, oncologic drug delivery research, and perioperative infectious disease screening.

Dr. Rajwani’s professional interests extend to consulting in clinical and research operations, health technology implementation, medical writing, and education. His career reflects a commitment to advancing translational science, improving critical care outcomes, and integrating research innovation into clinical practice.